Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 10, 2022 08:31 ET | Source: Neuronetics

NeuroStar Advanced Therapy for Mental Health Recognized as Top Neuromodulation Solution Provider in 2021

MALVERN, Pa., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
January 10, 2022 08:30 ET | Source: Neuronetics

Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2021 Financial Results

MALVERN, Pa., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
December 20, 2021 08:31 ET | Source: Neuronetics

Neuronetics Announces 510(k) Clearance of MT Cap Technology for NeuroStar® Advanced Therapy for Mental Health

MALVERN, Pa., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
December 06, 2021 08:31 ET | Source: Neuronetics

Neuronetics Announces Key Role for NeuroStar Advanced Therapy at 4th International Brain Stimulation Conference

MALVERN, Pa., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
November 22, 2021 16:30 ET | Source: Neuronetics

Neuronetics to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference

MALVERN, Pa., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
November 09, 2021 07:30 ET | Source: Neuronetics

Neuronetics Reports Third Quarter 2021 Financial and Operating Results

MALVERN, Pa., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
November 08, 2021 10:00 ET | Source: Neuronetics

Neuronetics and River Region Psychiatry Announce Exclusive Partnership

Partnership Will Bring Non-drug NeuroStar® Advanced Therapy For Mental Health To Thousands of Patients Across the Southeast MALVERN, Pa., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc....
October 26, 2021 08:30 ET | Source: Neuronetics

Neuronetics to Report Third Quarter 2021 Financial and Operating Results and Host Conference Call

MALVERN, Pa., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve...
October 26, 2021 08:30 ET | Source: Neuronetics

Neuronetics Celebrates 235,000 Treatment Milestone for Success TMS

MALVERN, Pa., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
October 19, 2021 20:15 ET | Source: Neuronetics

CORRECTION - Neuronetics Announces Preliminary Revenue for Third Quarter 2021

MALVERN, Pa., Oct. 19, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Tuesday, October 12th from Neuronetics, Inc. (NASDAQ: STIM), please note that the Safe Harbor Statement...